Who
James P. Boylan
Director
Company insider
Files Form 4 as: Director, Zenas BioPharma; Director, Immunome; Director, Compass Therapeutics; Director, CAMP4 Therapeutics.
In numbers
- Trades disclosed
- 14
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 4
- Companies where not an officer
- 4
- First trade
- 27 Oct 2023
- Last trade
- 15 Jun 2026
- Last filed
- 17 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Jun 2026filed 17 Jun 2026 | ZBIO Zenas BioPharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,500 at $0.00 | filing |
| 15 Jun 2026filed 17 Jun 2026 | ZBIO Zenas BioPharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,500 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | IMNM Immunomeoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,897 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | IMNM Immunomeoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,897 at $0.00 | filing |
| 2 Jan 2026filed 5 Jan 2026 | CMPX Compass Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —90,000 at $0.00 | filing |
| 2 Jan 2026filed 5 Jan 2026 | CMPX Compass Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —90,000 at $0.00 | filing |
| 25 Jun 2025filed 27 Jun 2025 | CAMP CAMP4 Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,000 at $0.00 | filing |
| 10 Jun 2025filed 12 Jun 2025 | ZBIO Zenas BioPharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,500 at $0.00 | filing |
| 10 Jun 2025filed 12 Jun 2025 | IMNM Immunomeoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,864 at $0.00 | filing |
| 11 Feb 2025filed 13 Feb 2025 | CMPX Compass Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 12 Sep 2024filed 16 Sep 2024 | ZBIO Zenas BioPharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —37,000 at $0.00 | filing |
| 13 Jun 2024filed 18 Jun 2024 | IMNM Immunomeoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,333 at $0.00 | filing |
| 8 Mar 2024filed 11 Mar 2024 | CMPX Compass Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 27 Oct 2023filed 31 Oct 2023 | IMNM Immunomeoption or derivative · Biotechnology | SEC FORM 4 Code A | —41,538 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.